250 related articles for article (PubMed ID: 17394434)
1. Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure.
Fragasso G
Int J Clin Pract; 2007 Apr; 61(4):603-10. PubMed ID: 17394434
[TBL] [Abstract][Full Text] [Related]
2. Metabolic therapy of heart failure.
Fragasso G; Salerno A; Spoladore R; Bassanelli G; Arioli F; Margonato A
Curr Pharm Des; 2008; 14(25):2582-91. PubMed ID: 18991675
[TBL] [Abstract][Full Text] [Related]
3. Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease.
Beadle RM; Frenneaux M
Heart; 2010 Jun; 96(11):824-30. PubMed ID: 20478861
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic therapy for heart failure].
Loiacono F; Alberti L; Lauretta L; Puccetti P; Silipigni C; Margonato A; Fragasso G
Recenti Prog Med; 2014; 105(7-8):288-94. PubMed ID: 25072544
[TBL] [Abstract][Full Text] [Related]
5. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
Lopaschuk GD
Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):228-30. PubMed ID: 16959756
[TBL] [Abstract][Full Text] [Related]
6. New directions in the treatment of heart failure: targeting free fatty acid oxidation.
Fragasso G; Spoladore R; Bassanelli G; Cuko A; Montano C; Salerno A; Margonato A
Curr Heart Fail Rep; 2007 Dec; 4(4):236-242. PubMed ID: 18221621
[TBL] [Abstract][Full Text] [Related]
7. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
Scolletta S; Biagioli B
Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
[TBL] [Abstract][Full Text] [Related]
8. Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolase.
Fragasso G; Spoladore R; Cuko A; Palloshi A
Curr Clin Pharmacol; 2007 Sep; 2(3):190-6. PubMed ID: 18690865
[TBL] [Abstract][Full Text] [Related]
9. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
10. Myocardial substrate metabolism in the normal and failing heart.
Stanley WC; Recchia FA; Lopaschuk GD
Physiol Rev; 2005 Jul; 85(3):1093-129. PubMed ID: 15987803
[TBL] [Abstract][Full Text] [Related]
11. Alterations in myocardial metabolism in the diabetic myocardium.
Lazar HL
Semin Thorac Cardiovasc Surg; 2006; 18(4):289-92. PubMed ID: 17395024
[TBL] [Abstract][Full Text] [Related]
12. Metabolic remodelling of the failing heart: beneficial or detrimental?
van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
[TBL] [Abstract][Full Text] [Related]
13. Anti-anginal effects of partial fatty acid oxidation inhibitors.
Lam A; Lopaschuk GD
Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
[TBL] [Abstract][Full Text] [Related]
14. The importance of inhibiting free fatty acid metabolism in heart failure treatment.
Jackson G
Int J Clin Pract; 2007 Apr; 61(4):535. PubMed ID: 17394423
[No Abstract] [Full Text] [Related]
15. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?
Lopaschuk GD
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S8-11. PubMed ID: 11286307
[TBL] [Abstract][Full Text] [Related]
16. Targets for modulation of fatty acid oxidation in the heart.
Lopaschuk GD
Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
[TBL] [Abstract][Full Text] [Related]
17. Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine.
Mobini R; Fu M; Jansson PA; Bergh CH; Scharin Täng M; Waagstein F; Andersson B
Clin Sci (Lond); 2006 Mar; 110(3):329-36. PubMed ID: 16209659
[TBL] [Abstract][Full Text] [Related]
18. Impaired energetics in heart failure - a new therapeutic target.
Ormerod JO; Ashrafian H; Frenneaux MP
Pharmacol Ther; 2008 Sep; 119(3):264-74. PubMed ID: 18602947
[TBL] [Abstract][Full Text] [Related]
19. [Effect of trimetazidine and perindopril on myocardial function and metabolism in patients with low cardiac output during postinfarction period].
Shabrov AV; Arkharov IV; Burbello AT; Makhnov AP
Ter Arkh; 2003; 75(9):77-81. PubMed ID: 14582440
[TBL] [Abstract][Full Text] [Related]
20. Myocardial glucose transport and utilization: a target for therapeutic intervention.
Singh PP; Lago RM; Nesto RW
Rev Cardiovasc Med; 2008; 9(2):106-10. PubMed ID: 18660731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
